Dudediligence.

Novavax, Inc

NVAXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$531,495

2 notices · 51,383 sh

PLANNED · FORM 144REPORTED · FORM 4none, Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-05-27: Ruxandra Draghia Akli, Form 1442026-05-07: Ruxandra Draghia Akli, Form 144
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-05-27Ruxandra Draghia Akli, EVP, Research & Development$235,412
21,383 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-07Ruxandra Draghia Akli, EVP, Research & Development$296,083
30,000 shno plan dateForm 4s on file end Jun 23144 ↗